Skip to main content
TipRanks
Go Ultimate75% OFF

Santen Pharmaceutical Co (SZD0) Q2 2026 Earnings Report

0 Followers

DE:SZD0 Q2 2026 EPS Results

Actual EPS
EUR 0.14
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 0.15

DE:SZD0 Q2 2026 Revenue Results

Actual Revenue
EUR 417.91M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-0.48%

Earnings Announcement Details

Quarter
Q2 2026
Date
11/05/2026
Time
TBA
Conference Call
Thursday, November 5, 2026
DE:SZD0 Upcoming Earnings

Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:SZD0 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:SZD0 Earnings History

DE:SZD0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 09, 20272026 (Q3)―-0.14――
Nov 05, 20262026 (Q2)―0.140.15-3.01% (-0.00)
Aug 06, 20262026 (Q1)―0.130.1116.67% (+0.02)
May 12, 20262025 (Q4)―0.280.1582.25% (+0.12)
Feb 05, 20262025 (Q3)―0.140.15-4.82% (-0.01)
Nov 06, 20252025 (Q2)―0.150.146.41% (+0.01)
Aug 07, 20252025 (Q1)―0.110.17-36.84% (-0.06)
May 13, 20252024 (Q4)―0.15016800.00% (+0.15)
Feb 06, 20252024 (Q3)―0.150.1318.57% (+0.02)
Nov 07, 20242024 (Q2)―0.140.15-8.24% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed